You should not breastfeed during treatment with SPRAVATO, Your healthcare provider will tell you how much SPRAVATO, During and after each use of the SPRAVATO, You will need to plan for a caregiver or family member to drive you home after taking SPRAVATO, If you take a nasal corticosteroid or nasal decongestant medicine take these medicines at least 1 hour before taking SPRAVATO, feeling disconnected from yourself, your thoughts, feelings and things around you, decreased feeling of sensitivity (numbness). NeuroMend Infusion Center is a Risk Evaluation and Mitigation Strategy (REMS) facility certified to provide SPRAVATO™ (esketamine), a nasal spray approved for … Please call the Johnson & Johnson Patient Assistance … Your healthcare provider will determine the dosing frequency based on how you feel. The majority of patients enrolled in the SHARES Copay Assistance … If you are able to become pregnant, talk to your healthcare provider about methods to prevent pregnancy during treatment with SPRAVATO®. Follow your SPRAVATO® treatment schedule exactly as your healthcare provider tells you to. It is not known if SPRAVATO® is safe or effective as an anesthetic medicine. This link is provided for your convenience. Spravato … Increased risk of suicidal thoughts and actions. Third party trademarks used herein are trademarks of their respective owners. SPRAVATO® is not for use in place of hospitalization if your healthcare provider determines that hospitalization is needed, even if improvement is experienced after the first dose of SPRAVATO®. Please see full Prescribing Information, including Boxed WARNINGS, and Medication Guide for SPRAVATO® and discuss any questions you may have with your healthcare provider. If you miss a SPRAVATO® treatment, your healthcare provider may change your dose and treatment schedule. If you are eligible, the Janssen CarePath Savings Program may provide savings on your out-of-pocket medication costs for SPRAVATO®. Not valid for patients using Medicare, Medicaid, or other government-funded programs to pay for their medications. Lost your health insurance? Spravato plus comprehensive standard of care appeared to lead to 15.9- and 16-point reductions on the Montgomery-Åsberg Depression Rating Scale in the two trials at 24 hours following … Depending on your health insurance plan, savings may apply toward co-pay, co-insurance, or deductible. Spravato (esketamine) nasal spray received FDA approval in March 2019 for Treatment Resistant Depression Therapy. Tell your healthcare provider right away if you feel like you cannot stay awake or if you feel like you are going to pass out. If you have Medicare Part D coverage but still have trouble paying for your prescriptions, there are charities that may be able to. Call a Janssen CarePath Care Coordinator at 844-777-2828 or visit JanssenPrescriptionAssistance.com for more information about affordability programs and independent foundations† that may have funding available. help. The SUPPRELIN ® LA Support Center will contact you if your child is eligible for this copay assistance program.. Treatment may include up to three devices administered on the same day. Adults with treatment-resistant depression (TRD) Depressive symptoms in adults with major … Apply for Extra Help. Depression and other serious mental illnesses are the most important causes of suicidal thoughts and actions. People who are currently struggling with major depressive disorder (MDD) may have treatment resistant depression (TRD) if … This site is published by Janssen Pharmaceuticals, Inc., which is solely responsible for its contents. Janssen CarePath can also help in reviewing with you and your healthcare provider your health plan benefits, insurance coverage and out-of-pocket costs. Here you'll find the financial assistance programs available for SPRAVATO®. Full Prescribing Information, including Boxed WARNINGS, Prescribing Information, including Boxed WARNINGS, Receive assistance paying their monthly premium, Have reduced or no prescription co-insurance and co-payments, Adults with treatment-resistant depression (TRD), Depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions. Taking SPRAVATO® with certain medicine may cause side effects. This program provides financial assistance … This site is intended for the use of patients and caregivers in the United States. SPRAVATO® is a prescription medicine, used along with an antidepressant taken by mouth to treat: SPRAVATO® is not for use as a medicine to prevent or relieve pain (anesthetic). SPRAVATO® may cause serious side effects including: The most common side effects of SPRAVATO® when used along with an antidepressant taken by mouth include: If these common side effects occur, they usually happen right after taking SPRAVATO® and go away the same day. What is the most important information I should know about SPRAVATO®? helps find financial assistance options for eligible patients, and provides ongoing support to help patients start and stay on SPRAVATO™ treatment that you prescribed. Treatment may include up to three devices administered on the same day. If you have any questions about the SPRAVATO ® REMS or need help with certification or enrollment, call 1-855-382-6022 Monday - Friday 8AM - 8PM ET For SPRAVATO ® REMS Program information contact: … Pay close attention to any changes, especially sudden changes, in mood, behavior, thoughts, or feelings, or if you develop suicidal thoughts or actions. To see if you might qualify for assistance, please contact a JJPAF program specialist at 800-652-6227 (Monday–Friday, 9:00 AM to 6:00 PM ET) or visit the foundation website at JJPAF.org. If you qualify for Extra Help… other unusual changes in behavior or mood, have blood vessel (aneurysmal vascular) disease (including in the brain, chest, abdominal aorta, arms and legs), have an abnormal connection between your veins and arteries (arteriovenous malformation). To learn more about your insurance coverage for SPRAVATO® and other resources, please call a Janssen CarePath Care Coordinator at 844-777-2828 or visit JanssenCarePath.com. Janssen CarePath can provide information about other resources that may be able to help with your out-of-pocket medication costs for SPRAVATO®. pay for prescriptions. The Prescribing Information included here may not be appropriate for use outside the United States and its territories. are pregnant or plan to become pregnant. What should I avoid while taking SPRAVATO®? 5. Taking SPRAVATO® with certain medicine may cause side effects. The Benefits of Spravato. These include people who have (or have a family history of) depression or a history of suicidal thoughts or actions. are pregnant or plan to become pregnant. All rights reserved. A report from your pharmacy or an Explanation of Benefits (EOB) statement ... SPRAVATO®* (esketamine) Nasal Spray CIII, for intranasal use ... patient assistance … There is a risk for abuse and physical and psychological dependence with SPRAVATO® treatment. other unusual changes in behavior or mood, have blood vessel (aneurysmal vascular) disease (including in the brain, chest, abdominal aorta, arms and legs), have an abnormal connection between your veins and arteries (arteriovenous malformation), are allergic to esketamine, ketamine, or any of the other ingredients in SPRAVATO, slow or fast heartbeats that cause shortness of breath, chest pain, lightheadedness, or fainting, history of brain injury or any condition where there is increased pressure in the brain. You can also click here to learn more about Janssen's COVID-19 response. Call a Janssen CarePath Care Coordinator … This site is published by Johnson & Johnson Health Care Systems Inc. You will need to plan for a caregiver or family member to drive you home after taking SPRAVATO®. Check the Health Insurance Marketplace at www.HealthCare.gov to see if you can enroll in a plan. For full eligibility requirements, click here. slow or fast heartbeats that cause shortness of breath, chest pain, lightheadedness, or fainting, history of brain injury or any condition where there is increased pressure in the brain. It is not known if SPRAVATO® is safe and effective in children. Please check back, as programs change. Many states have programs for people with limited income and resources that pay some or all of Medicare's premiums and may pay Medicare deductibles and co-insurance. Program limits apply. Call your healthcare provider between visits as needed, especially if you have concerns about symptoms. Before you take SPRAVATO®, tell your healthcare provider about all of your medical conditions, including if you: Tell your healthcare provider about all the medicines that you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. Keep a list of them to show to your healthcare provider and pharmacist when you get a new medicine. Your healthcare provider should check you for signs of abuse and dependence before and during treatment with SPRAVATO®. Abuse and misuse. These are not all the possible side effects of SPRAVATO®. Treatment may include up to three devices administered on the same day. Charity programs that help. You will take SPRAVATO® nasal spray yourself, under the supervision of a healthcare provider in a healthcare setting. Last updated on . Program does not cover the cost to give you your treatment. Because of the risks for sedation, dissociation, and abuse and misuse, SPRAVATO® is only available through a restricted program called the SPRAVATO® Risk Evaluation and Mitigation Strategy (REMS) Program. Pay close attention to any changes, especially sudden changes, in mood, behavior, thoughts, or feelings, or if you develop suicidal thoughts or actions. What are the possible side effects of SPRAVATO®? SPRAVATO® can cause serious side effects, including: Sedation and dissociation. Tell your healthcare provider about all the medicines that you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. We want to guide you to programs that may help. Eligible patients may save up to $2,000 on each SUPPRELIN ® LA prescription after a $10 copay. It is not known if SPRAVATO® is safe and effective in children. It acts on receptors (targets) in the brain for a substance called NMDA. CONCERTA® (methylphenidate HCI) Extended-release Tablets CII, ELMIRON® (pentosan polysulfate sodium) Capsules, INVEGA SUSTENNA® (paliperidone palmitate) extended-release injectable suspension 39mg, 78mg, 117mg, 156mg, or 234mg, INVEGA TRINZA® (paliperidone palmitate) extended-release injectable suspension 273mg, 410mg, 546mg, or 819mg, INVOKAMET® (canagliflozin/metformin HCl) tablets, INVOKAMET® XR (canagliflozin/metformin HCl extended-release) tablets, PREZCOBIX® (darunavir 800 mg/ cobicistat 150 mg) tablets, RAZADYNE® ER (galantamine HBr) Extended-Release Capsules, SYMTUZA® (darunavir/cobicistat/emtricitabine/tenofovir alafenamide). To view programs that are best suited for you, select your coverage status for SPRAVATO® or view all assistance programs. During and after each use of the SPRAVATO® nasal spray device, you will be checked by a healthcare provider who will decide when you are ready to leave the healthcare setting. The Low-Income Subsidy (LIS) program from Medicare provides financial assistance for patients who may otherwise be unable to afford the costs associated with their Medicare Part D plan. SPRAVATO® may harm your baby. SPRAVATO® can only be administered at healthcare settings certified in the SPRAVATO® REMS Program. No matter what type of coverage you have – or even if you don’t have coverage – Janssen CarePath can help explain your medication insurance coverage and potential out-of-pocket costs and help find programs that may help you pay for SPRAVATO®. Before you take SPRAVATO®, tell your healthcare provider about all of your medical conditions, including if you: have ever had a condition called "psychosis" (see, feel, or hear things that are not there, or believe in things that are not true). Antidepressant medicines may increase suicidal thoughts and actions in some people 24 years of age and younger, especially within the first few months of treatment or when the dose is changed. After receiving final approval, initial monthly costs look to be near $7,000 a month… yikes. Third party trademarks used herein are trademarks of their respective owners. *2019 financial assistance amount was determined by the total amount billed to and paid by manufacturer and charitable financial assistance … financial criteria may also be eligible for assistance. Eligible patients with commercial insurance can receive savings on out-of-pocket medication costs for SPRAVATO®. https://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/antidepressants/, Adults with treatment-resistant depression (TRD), Depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions. These include people who have (or have a family history of) depression or a history of suicidal thoughts or actions. SPRAVATO® may cause serious side effects including: The most common side effects of SPRAVATO® when used along with an antidepressant taken by mouth include: If these common side effects occur, they usually happen right after taking SPRAVATO® and go away the same day. Find out if your state has a program that can help you ». You should not eat for at least 2 hours before taking SPRAVATO® and not drink liquids at least 30 minutes before taking SPRAVATO®. What should I avoid while taking SPRAVATO®? You should not take SPRAVATO® if you are pregnant. It is not known if SPRAVATO® is safe and effective for use in preventing suicide or in reducing suicidal thoughts or actions. We are here to support you during COVID-19. Tell your healthcare provider right away if you have any new or sudden changes in mood, behavior, thoughts, or feelings. Please note that this third-party website is not controlled by Janssen or subject to our Privacy Policy. There is a quantity limit of 24 devices in a 24-day period for one use per lifetime. Depending on how your insurance covers SPRAVATO®, there is a program benefit limit of list price of the medication and a quantity limit of three devices per day or 23 devices in a 24-day period. We do not endorse any particular foundation. Depending on how their insurance covers SPRAVATO®, there is a program benefit limit of list price of … NMDA regulates the transmission of signals between cells in brain areas involved in the regulation of mood. SPRAVATO® is not for use in place of hospitalization if your healthcare provider determines that hospitalization is needed, even if improvement is experienced after the first dose of SPRAVATO®. have ever had a condition called “psychosis” (see, feel, or hear things that are not there, or believe in things that are not true). Your healthcare provider will tell you how much SPRAVATO® you will take and when you will take it. feeling disconnected from yourself, your thoughts, feelings and things around you, decreased feeling of sensitivity (numbness). Program limits apply. SPRAVATO® can cause serious side effects, including: If you are not sure if you have any of the above conditions, talk to your healthcare provider before taking SPRAVATO®. SPRAVATO ® is a prescription medicine, used along with an antidepressant taken by mouth to treat: . See “What is the most important information I should know about SPRAVATO®?”. Independent co-pay assistance foundations have their own rules for eligibility. At the current time, patient affordability programs for the selected insurance option are not available for this product. The use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy. Especially tell your healthcare provider if you take central nervous system (CNS) depressants, psychostimulants, or monoamine oxidase inhibitors (MAOIs) medicines. We cannot guarantee a foundation will help you. SPRAVATO, Tell your healthcare provider right away if you become pregnant during treatment with SPRAVATO, If you are able to become pregnant, talk to your healthcare provider about methods to prevent pregnancy during treatment with SPRAVATO, There is a pregnancy registry for women who are exposed to SPRAVATO, are breastfeeding or plan to breastfeed. Depression and other serious mental illnesses are the most important causes of suicidal thoughts and actions. Here you'll find the financial assistance programs available for SPRAVATO… Your healthcare provider can tell you more about the differences between physical and psychological dependence and drug addiction. Tell your healthcare provider if you have ever abused or been dependent on alcohol, prescription medicines, or street drugs. Depending on how your insurance covers SPRAVATO®, there is a program benefit limit of list price of the medication and a quantity limit of three devices per day or 23 devices in a 24-day period. Spravato is a rapid-acting, nasal spray formulation of a non-competitive receptor antagonist N-methyl D-aspartate (NMDA). SPRAVATO® Risk Evaluation and Mitigation Strategy (REMS). Register for the Savings Program at Register.JanssenCarePathSavings.com to get a card for use at your healthcare provider’s office or pharmacy. How long will I stay on SPRAVATO® for treatment-resistant depression? The material on this site is intended only as informational or as an educational aid and it is not intended to be taken as medical advice. Neuromend Infusion Center and Spravato. Esketamine is the s-enantiomer of the anesthetic ketamine, which was first … You may be eligible for one or more of the following programs: To view programs that are best suited for you, select your insurance status for SPRAVATO® or view all assistance programs. Will my insurance cover treatment with SPRAVATO®? Janssen CarePath helps verify insurance coverage for your patients, provides reimbursement information, helps find financial assistance options for eligible patients, and provides ongoing support to help patients start and stay on the SPRAVATO… SPRAVATO® is a prescription medicine, used along with an antidepressant taken by mouth to treat: SPRAVATO® is not for use as a medicine to prevent or relieve pain (anesthetic). How can I watch for and try to prevent suicidal thoughts and actions in myself or a family member? In a historic vote, the FDA has approved Janssen Pharmaceutical’s new medication, Spravato™, for clinical depression.This is the first time that … We do not endorse any particular foundation. Call a Janssen CarePath Care Coordinator at 844-777 … Your healthcare provider must monitor you for serious side effects for at least 2 hours after taking SPRAVATO. We cannot guarantee a foundation will help you. Home. are allergic to esketamine, ketamine, or any of the other ingredients in SPRAVATO®. Especially tell your healthcare provider if you take central nervous system (CNS) depressants, psychostimulants, or monoamine oxidase inhibitors (MAOIs) medicines. See "What is the most important information I should know about SPRAVATO®?". Not valid for patients using Medicare, Medicaid or other government-funded programs to pay for their medications. Services. Laws, regulatory requirements and medical practices for pharmaceutical products vary from country to country. Learn how cost assistance programs can help people with … Some states have expanded their Medicaid programs to cover all people below certain income levels. Tell your healthcare provider if you have ever abused or been dependent on alcohol, prescription medicines, or street drugs. Insurance providers are now offering coverage for SPRAVATO™! The healthcare providers at your certified SPRAVATO® treatment center may be able to assist you in determining your insurance coverage for SPRAVATO® and potential out-of-pocket costs of treatment. Some people may have a higher risk of having suicidal thoughts or actions. The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is an independent, non-profit organization that is committed to helping eligible patients without insurance coverage receive … Do not drive, operate machinery, or do anything where you need to be completely alert after taking SPRAVATO®. The purpose of the registry is to collect information about the health of women exposed to SPRAVATO® and their baby. Please see full Prescribing Information, including Boxed WARNINGS, and Medication Guide for SPRAVATO® and discuss any questions you may have with your healthcare provider. Some Medicare Part D patients who cannot afford their medicines, and who meet certain financial criteria, may also be eligible for assistance. Medicare patients who have limited income and resources may qualify for "extra help" to pay for prescription drugs. This information is intended for the use of patients and caregivers in the United States and its territories only. Janssen CarePath can provide information about this program as well as other resources that may be able to help with your out-of-pocket medication costs for SPRAVATO®. Once you and your doctor have decided that SPRAVATO ® is right for you, Janssen CarePath will help you find the resources you may need to get started and stay on track. Not valid for patients using Medicare, Medicaid, or other government-funded programs to pay for their medications. Benefits. Once you and your healthcare provider have decided SPRAVATO® is right for you, Janssen CarePath can help you find the resources you may need to help get started and stay on track. The active substance in Spravato, esketamine, is an antidepressant. are breastfeeding or plan to breastfeed. See full eligibility requirements. Call your doctor for medical advice about side effects. Some states sponsor prescription financial assistance programs, each with its own eligibility requirements. If you are using a government-funded healthcare program to pay for SPRAVATO® or have no insurance coverage and need help paying for your medication: Janssen CarePath can provide information about other resources that may be able to help with your out-of-pocket medication costs for SPRAVATO®. It is not known if SPRAVATO® is safe and effective for use in preventing suicide or in reducing suicidal thoughts or actions. This information is provided as a resource for you. You may report side effects to FDA at 1-800-FDA-1088. Hygeia Health Solutions’ stigma-free buprenorphine program in conjunction with your treatment protocol can help improve patient adherence to their treatment plan. The ultimate responsibility for patient care resides with a healthcare professional. You and your healthcare provider will decide how long you stay on SPRAVATO® based on how you respond to it and how stable that response is. Spravato (esketamine) is a member of the miscellaneous antidepressants drug class and is commonly used for Depression, and Major Depressive Disorder. Call a Janssen CarePath Care … You may report side effects to FDA at 1-800-FDA-1088. Thank you for visiting our site. Transfer Rx. The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is a nonprofit organization that assists U.S. patients without adequate financial resources and prescription coverage … Keep all follow-up visits with your healthcare provider as scheduled. Some of these programs may also help … Don’t let a copay stand in your way. Spravato Prices, Coupons and Patient Assistance Programs.